VERSI EBRAHIM (CEO) reported 1 transaction at DMK PHARMACEUTICALS CORP
Review the transaction codes below to understand the nature of each event.
Filed: 9/19/2023ACC: 0001387131-23-011359
DirectorOfficer· CEO
Since May 2023
+728.47K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
729.20K acquired · 729.20 disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+729.20K
Price / share
—
Trade value
—
% of position
411.5%
9/15/2023
177.19K→906.39K
Total
Net shares
+729.20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/15/2023 | C · Conversion | +729.20K | — | — | 411.5% | 177.19K | 906.39K |
| Total | +729.20K | $0.00 | ||||||
Derivative Transactions1
Series E Convertible Preferred Stock
Indirect
Converts to
Common Stock
729.20K shares
Shares
−729.20
Strike price
Held after
1.21K
Exercisable
—
9/15/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series E Convertible Preferred Stock Indirect | Common Stock729.20K shares | 9/15/2023 | C · Conversion | −729.20 | — | 1.21K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned8.74K
Total
8.74K direct8.74K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 8.74K | Direct |
| Total | 8.74K | 8.74K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported